Skip to content

Study on new technology for treatment of post-traumatic depression

Study on new technology for treatment of post-traumatic depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017711
Enrollment
Unknown
Registered
2018-08-10
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Study group1:Western medicine program (therapeutic method is the same as the control group) + simulated transcutaneous electrical acupoint stimulation combined with cognitive behavioral
Study group2:Western medicine program (therapeutic method is the same as the control group) + transcutaneous electrical acupoint stimulation combined with cognitive behavioral.
Control group:Continue the western medicine treatment plan according to the Guidelines for Prevention and Treatment of Depressive Disorders edited by the Chinese Medical Association

Sponsors

Tongde Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria for DSM-V major depressive episodes; (2) Hamilton rating scale for depression (HAMD) 24 scores > 21 points; (3) The total score of the social re-adaptation scale is >200 points; (4) Male and female aged 18-65 years old; (5) Get informed consent.

Exclusion criteria

Exclusion criteria: (1) With serious heart, liver and kidney diseases, brain organic diseases, serious cardiovascular diseases, tumors, blood history, rheumatism, malnutrition and nervous system degeneration; secondary to other mental illnesses or bodies Depressive episodes of the disease; (2) With history of abuse of tobacco, alcohol and other psychoactive substances; (3) pregnant women; (4) Bipolar disorder; (5) Those who have done ECT within 6 months before enrollment; (6) Those who had done rTMS before enrollment.

Design outcomes

Primary

MeasureTime frame
resting magnetic resonance imaging;resting magnetic resonance imaging;resting magnetic resonance imaging;

Countries

China

Contacts

Public ContactLIU LAN YING

Tongde Hospital of Zhejiang Province

balindaliu@163.com+86 13516816012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026